Mattessich Antony C. Insider Trades

Insider Trading History

Track insider trading activity for Mattessich Antony C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aura Biosciences
Aura Biosciences AURA
Director
Holding Value $270k 38,500 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$279k 45,000 shares
$6.21
$7.01
Aura Biosciences
Aura Biosciences AURA
Director
Holding Value $165k 23,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$105k 17,000 shares
$6.18
$7.01
Aura Biosciences
Aura Biosciences AURA
Director
Holding Value $102k 14,500 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 14,500 shares
$6.93
$7.01
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $5.86M 588,701 shares
Last Trade
Feb 05, 2024 Purchase (Open Market)Shares sold on the open market or in a private sale.
$95.5k 19,642 shares
$4.86
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $6.06M 608,343 shares
Last Trade
Feb 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.85M 549,400 shares
$5.18
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $4.26M 427,943 shares
Last Trade
Jan 31, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$90.8k 18,338 shares
$4.95
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $64.7k 6,500 shares
Last Trade
Aug 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.8k 6,500 shares
$3.81
$9.96
Aura Biosciences
Aura Biosciences AURA
Director
Holding Value $112k 16,000 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 16,000 shares
$12.83
$7.01
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $4.44M 446,281 shares
Last Trade
Feb 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$83.4k 19,669 shares
$4.24
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $5.35M 536,900 shares
Last Trade
Jan 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.08M 536,900 shares
$3.88
$9.96
Aura Biosciences
Aura Biosciences AURA
Director
Holding Value $112k 16,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 16,000 shares
$13.72
$7.01
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $5.58M 560,200 shares
Last Trade
Feb 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.95M 560,200 shares
$5.27
$9.96
Aura Biosciences
Aura Biosciences AURA
Director
Holding Value $0 0 shares
Last Trade
Oct 28, 2021 Sale
No data
No data
$7.01
Aura Biosciences
Aura Biosciences AURA
Director
Holding Value $112k 16,000 shares
Last Trade
Oct 28, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$7.01
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $1.02M 102,900 shares
Last Trade
Aug 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49.5k 5,000 shares
$9.89
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $4.53M 455,000 shares
Last Trade
Feb 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.33M 455,000 shares
$18.31
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $3.59M 360,000 shares
Last Trade
Jan 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 360,000 shares
$4.39
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President & CEO
Holding Value $975k 97,900 shares
Last Trade
Jun 06, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$112k 40,000 shares
$2.81
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President And CEO
Holding Value $3.98M 400,000 shares
Last Trade
Jan 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.64M 400,000 shares
$4.10
$9.96
Ocular Therapeutix
Ocular Therapeutix OCUL
President & CEO
Holding Value $577k 57,900 shares
Last Trade
Aug 20, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$119k 20,000 shares
$5.95
$9.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up